0001415889-22-007602.txt : 20220708
0001415889-22-007602.hdr.sgml : 20220708
20220708174258
ACCESSION NUMBER: 0001415889-22-007602
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220707
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN LOUIS W
CENTRAL INDEX KEY: 0001193522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 221075422
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN LOUIS
DATE OF NAME CHANGE: 20020927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-07082022_020747.xml
X0306
4
2022-07-07
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001193522
SULLIVAN LOUIS W
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
Common Stock
2022-07-08
4
M
0
3230
0
A
14330
D
Restricted Stock Unit
0
2022-07-08
4
M
0
3230
0
D
2022-07-08
Common Stock
3230
0
D
Restricted Stock Unit
0
2022-07-07
4
A
0
880
0
A
2023-07-07
Common Stock
880
880
D
Stock Options
240.20
2022-07-07
4
A
0
2490
0
A
2023-07-07
2032-07-07
Common Stock
2490
2490
D
Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
Annual non-employee director award.
/s/ John S. Hess, Jr. under Power of Attorney
2022-07-08